Education
About Us
Working with TipRanks
Follow Us
DarioHealth Corp (DRIO)
NASDAQ:DRIO
Total Valuation
DarioHealth has a market cap or net worth of $33.25M. The enterprise value is $31.73M.
Market Cap$33.25M
Enterprise Value$31.73M
Share Statistics
DarioHealth has 41,567,017 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,567,017
Owned by Insiders6.21%
Owned by Institutions15.44%
Financial Efficiency
DarioHealth’s return on equity (ROE) is 0.57 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.57
Return on Assets (ROA)0.34
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)-0.56
Revenue Per Employee137.96K
Profits Per Employee-218.10K
Employee Count196
Asset Turnover0.23
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of DarioHealth is 1.29. DarioHealth’s PEG ratio is >-0.01.
PE Ratio1.29
PS Ratio1.06
PB Ratio0.73
Price to Fair Value0.73
Price to FCF-1.36
Price to Operating Cash Flow-1.37
PEG Ratio>-0.01
Income Statement
In the last 12 months, DarioHealth had revenue of 27.04M and earned 40.98M in profits. Earnings per share was 0.61.
Revenue27.04M
Gross Profit13.27M
Operating Income-57.74M
Pretax Income40.98M
Net Income40.98M
EBITDA-57.74M
Earnings Per Share (EPS)0.61
Cash Flow
In the last 12 months, operating cash flow was -38.56M and capital expenditures -138.00K, giving a free cash flow of -38.70M billion.
Operating Cash Flow-38.56M
Free Cash Flow-38.70M
Free Cash Flow per Share-0.93
Dividends & Yields
DarioHealth pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.88
52-Week Price Change-45.95%
50-Day Moving Average0.68
200-Day Moving Average0.84
Relative Strength Index (RSI)63.55
Average Volume (3m)321.88K
Important Dates
DarioHealth upcoming earnings date is May 20, 2025, TBA Not Confirmed.
Last Earnings DateMar 10, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
DarioHealth as a current ratio of 1.72, with Debt / Equity ratio of 41.92%
Current Ratio1.72
Quick Ratio1.72
Debt to Market Cap0.57
Net Debt to EBITDA-0.04
Interest Coverage Ratio0.00
Taxes
In the past 12 months, DarioHealth has paid 40.98M in taxes.
Income Tax40.98M
Effective Tax Rate1.00
Enterprise Valuation
DarioHealth EV to EBITDA ratio is -0.96, with an EV/FCF ratio of -1.43.
EV to Sales2.04
EV to EBITDA-0.96
EV to Free Cash Flow-1.43
EV to Operating Cash Flow-1.43
Balance Sheet
DarioHealth has $28.46M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.73M billion.
Cash & Marketable Securities$28.46M
Total Debt$0.00
Net Cash$1.73M
Net Cash Per Share$0.04
Tangible Book Value Per Share-$0.06
Margins
Gross margin is 49.06%, with operating margin of -213.55%, and net profit margin of 151.56%.
Gross Margin49.06%
Operating Margin-213.55%
Pretax Margin151.56%
Net Profit Margin151.56%
EBITDA Margin-213.55%
EBIT Margin0.00%
Analyst Forecast
The average price target for DarioHealth is $1.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$1.50
Price Target Upside87.50% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast32.86%
EPS Growth Forecast60.00%